California-based Capstan Medical, maker of robotic-enabled tools for heart valve disease, closed an oversubscribed $110 million Series C round led by Eclipse. Existing investors Intuitive Ventures, Yu Galaxy, and new investor Gideon Strategic Partners, participated…
Continue Reading
What You Should Know:
– Capstan Medical, a medical technology company developing innovative solutions for heart valve disease secures $110M in a Series C funding round led by Eclipse with participation from existing investors Yu…
Continue Reading
What You Should Know: – Intuitive Ventures, an early-stage venture capital fund dedicated to reimagining minimally invasive care, announced the close of its second fund at $150M. – The funding signifies their unwavering commitment…
Continue Reading
The fourth quarter of the year is a fitting time to look back and look ahead to consider investment trends in healthcare and what to expect in 2024. In response to emailed questions, investors…
Continue Reading
What You Should Know: Today, Santa Cruz-based Capstan Medical, a developer of minimally invasive technology to address heart valve disease, announced $31.4M Series B investment round led by Eclipse.The Series B round included participation…
Continue Reading
